Company Information

  

Address: 16 ZE'EV TYOMKIN ST. (4TH FL.)  
City: TEL AVIV 
State:  
Zip Code: 6578317 
Telephone: 97236938448 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Our Company, Galmed Pharmaceuticals Ltd., was incorporated in Israel on July 31, 2013 as a privately held company and is governed by the Companies Law. However, our business has been operating since 2000 under a different group of companies established in the same year (the "Group"). Originally, we operated under the parent company, GHI. GHI held all of the equity rights in and to GTTI. GTTI held all of the equity rights in and to GIL (other than 0.1% of the share capital held by GHI). GIL held all of the equity rights in and to GMR. Our intellectual property was held by GIL. The research and development was conducted by GMR as a service to GIL on a cost plus basis. GIL was responsible for all product development. On February 2, 2014, we underwent the Reorganization, pursuant to which all of our intangible assets (including our intellectual property) were transferred from GIL to GRD.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/20170.98NA9.34
12/20161.49NA2.36
12/20150.96NA7.93

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.13Total Liab/Total Assets0.20
Net Inc/Total Assets-0.63Total Liab/Inv Cap0.24
Net Inc/Inv Cap-0.78Total Liab/Comm Equity0.04
Pretax Inc/Net Sales-11.34Interest Coverage RatioNA
Net Inc/Net Sales-11.34Curr Debt/EquityNA
Cash Flow/Net Sales-11.12LTD/EquityNA
SG&A/NetSales3.50Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover4.94Quick Ratio4.98
Inventory TurnoverNACurrent Ratio4.98
Inventory Day SalesNANet Rec/Curr Assets0.01
Net Sales/Work Cap0.07Inv/Curr AssetsNA
Net Sales/PP&E2.21  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) 1.09 0.47 0.00 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 3.80 3.08 3.25 2.48
Operating Income -12.36 -16.88 -10.88 -9.14
Interest Exp NA NA NA NA
Pretax Income -12.30 -16.85 -10.62 -9.10
Other Income 0.07 0.04 0.25 0.04
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -12.30 -16.95 -10.62 -9.10

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 19.00 15.45 23.00 25.99
Receivables - Total 0.16 0.28 0.38 0.17
Inventories - Total NA NA NA NA
Total Current Assets 19.15 15.73 23.38 32.15
Net Property, Plant & Equipment 0.49 0.72 0.88 0.77
Total Assets 19.64 16.45 24.26 32.93
Liabilities        
Accounts Payable 3.31 3.49 2.54 1.12
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 3.85 4.58 2.54 1.12
Long-Term Debt NA NA NA NA
Total Liabilities 3.85 5.38 2.72 1.52
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.04 0.03 0.03 0.03
Retained Earnings -76.62 -64.32 -47.37 -36.75
Treasury Stock NA NA NA NA
Total Stockholders' Equity 15.80 11.08 21.55 31.41
Total Liabilities and Stockholders' Equity 19.64 16.45 24.26 32.93

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities -12.07 -12.13 -8.47 -9.24
Net Cash Provided by Investing Activities 6.44 6.34 -11.11 -9.02
Net Cash Provided by Financing Activities 15.55 4.73 0.00 41.86

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.00-17.48--
12/20140.00-9.10--
12/20150.00-10.620.96
12/20160.47-16.951.49
12/20171.08-12.300.98
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18232,65412.70




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.